Zobrazeno 1 - 8
of 8
pro vyhledávání: '"P M Deckert"'
Autor:
C. Henzler, T. Henzler, D. Buchheidt, John W. Nance, C. A. Weis, R. Vogelmann, U. Benck, T. Viergutz, T. Becher, T. Boch, S. A. Klein, D. Heidenreich, L. Pilz, M. Meyer, P. M. Deckert, W.-K. Hofmann, S. O. Schoenberg, M. Reinwald
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Abstract Invasive pulmonary aspergillosis (IPA) is one of the major complications in immunocompromised patients. The mainstay of diagnostic imaging is non-enhanced chest-computed-tomography (CT), for which various non-specific signs for IPA have been
Externí odkaz:
https://doaj.org/article/07a7934a19f94141a338e22488859379
Autor:
Lothar R. Pilz, Cleo-Aron Weis, Stefan O. Schoenberg, Mark Reinwald, Mathias Meyer, Thomas Henzler, Daniela Heidenreich, Wolf-K. Hofmann, Tobias Becher, John W. Nance, P. M. Deckert, Claudia Henzler, Tim Viergutz, R. Vogelmann, Dieter Buchheidt, Tobias Boch, Urs Benck, Sabrina Klein
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Scientific Reports
Scientific Reports
Invasive pulmonary aspergillosis (IPA) is one of the major complications in immunocompromised patients. The mainstay of diagnostic imaging is non-enhanced chest-computed-tomography (CT), for which various non-specific signs for IPA have been describe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f90ede7199480131afd7edd3325d3d56
https://doaj.org/article/07a7934a19f94141a338e22488859379
https://doaj.org/article/07a7934a19f94141a338e22488859379
Autor:
P M Deckert
Publikováno v:
Current Drug Targets. 10:158-175
Almost ever since their invention, monoclonal antibodies have held the promise of cancer-specific drug targeting--Paul Ehrlich's "magic bullet"--but only during the past decade have a modest number of anti-cancer antibodies received approval for clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b491bb80ed3b64780c42c1d87033418d
https://doi.org/10.2174/138945009787354502
https://doi.org/10.2174/138945009787354502
Autor:
Ronald D. Finn, P. M. Deckert, Richards Elizabeth C, Nicholas J. Montalto, M. A. Clark, C. Williams, Sydney Welt, Achim A. Jungbluth, Katherine S. Panageas, L. J. Old
Publikováno v:
International Journal of Cancer. 87:382-390
Therapeutic proteins have been conjugated with polyethylene glycol (PEGylation) to reduce immunogenicity and enhance circulating dose. Here we have investigated the effect of PEGylation on immunogenicity, pharmacokinetics, and histologic microdistrib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be921de45d9b3df15a3a9a9984577e32
https://doi.org/10.1002/1097-0215(20000801)87:3<382::aid-ijc12>3.0.co
https://doi.org/10.1002/1097-0215(20000801)87:3<382::aid-ijc12>3.0.co
Publikováno v:
The Journal of Immunology. 156:826-833
Anti-idiotypic vaccination against HIV infection aims at inducing an anti-gp120 immune response through anti-CD4 Abs mimicking epitopes of the gp120 molecule. The mAb IOT4a induces anti-gp120 Abs in rabbits. This study investigates the presence of hu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81644af18b918603773feb257c63533f
https://doi.org/10.4049/jimmunol.156.2.826
https://doi.org/10.4049/jimmunol.156.2.826
Publikováno v:
Cancer chemotherapy and pharmacology. 54(2)
Oxaliplatin and topotecan are novel options for a variety of neoplasms. Topotecan has shown fewer side effects and higher efficacy when given as a continuous i.v. infusion compared to single doses, but this regimen has not yet been combined with oxal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::891fdfc4b1b832a860c3c1d44ab9f361
https://pubmed.ncbi.nlm.nih.gov/15114411
https://pubmed.ncbi.nlm.nih.gov/15114411
Autor:
P M, Deckert, A, Jungbluth, N, Montalto, M A, Clark, R D, Finn, C, Williams, E C, Richards, K S, Panageas, L J, Old, S, Welt
Publikováno v:
International journal of cancer. 87(3)
Therapeutic proteins have been conjugated with polyethylene glycol (PEGylation) to reduce immunogenicity and enhance circulating dose. Here we have investigated the effect of PEGylation on immunogenicity, pharmacokinetics, and histologic microdistrib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::443abe01d1ad67f58c019b207daf2f1c
https://pubmed.ncbi.nlm.nih.gov/10897044
https://pubmed.ncbi.nlm.nih.gov/10897044
Autor:
Ulrich Keilholz, Eckhard Thiel, J. M. Siehl, P. M. Deckert, H. Szélenyi, Gero Hütter, Alexander Schmittel
Publikováno v:
Journal of Clinical Oncology. 22:9011-9011
9011 Background: Anthracycline/ifosfamide combination is the most effective chemotherapy in soft tissue sarcoma. To improve tolerability and potentially efficacy of this combination we combined lip...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d59dcec9bfc631c678f8b7c7563cf5f
https://doi.org/10.1200/jco.2004.22.90140.9011
https://doi.org/10.1200/jco.2004.22.90140.9011